Sort
38,696 grants matching “als”
Delivery of therapeutic genes in motor neuron disease
$1,679,896Arthur H.m Burghes · Ohio State University · RC2 · FY2009 · NS
Biological And Biochemical Characterization Of Sigma Receptors
$1,679,280Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2023 · DA
Frontotemporal Dementia: Genes, Images and Emotions
$1,678,903Bruce L Miller · University Of California, San Francisco · P01 · FY2009 · AG
BRAIN CONNECTS: Multi-beam transmission electron microscopy of iteratively milled semi-thick tissue sections
$1,678,795Adrian Andreas Wanner · Paul Scherrer Institut Psi · U01 · FY2023 · NS
The physical biology of neurodegeneration in sporadic Amyotrophic Lateral Sclerosis/Frontotemporal dementia
$1,677,797Hemali Phatnani · Columbia University Health Sciences · R01 · FY2022 · NS
Characterization of neuronal ensembles activated during drug-induced behavior
$1,677,722Bruce Hope · National Institute On Drug Abuse · ZIA · FY2013 · DA
Neuronal avalanches in the neocortex
$1,677,206Dietmar Plenz · National Institute Of Mental Health · ZIA · FY2014 · MH
Neuroimmune responses and therapeutics of alpha-synucleinopathies of the aging population
$1,676,951Eliezer Masliah · National Institute On Aging · ZIA · FY2019 · AG
A fully implantable speech neuroprosthesis
$1,675,966Peng Cong · University Of California, San Francisco · UG3 · FY2025 · NS
Delivery of therapeutic genes in motor neuron disease
$1,674,836Arthur H.m Burghes · Ohio State University · RC2 · FY2010 · NS
Role of Neuroendocrine Stress Response in Inflammatory and Behavioral Illness.
$1,674,760Esther M. Sternberg · National Institute Of Mental Health · ZIA · FY2011 · MH
Lung Connective Tissue-Responses to Injury And Repair
$1,674,183Boston University Medical Campus · P01 · FY2002 · HL
Genome-wide analysis of chromatin modifications
$1,673,927Keji Zhao · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Commercialization Readiness Pilot (CRP) to maximize vamorolone international labeling and sales
$1,672,364Eric P Hoffman · Reveragen Biopharma, Inc. · SB1 · FY2021 · NS
Neuregulin-ErbB Signaling in Neuronal Development and Psychiatric Disorders
$1,671,973Andres Buonanno · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD
Neuronal avalanches in the neocortex
$1,671,747Dietmar Plenz · National Institute Of Mental Health · ZIA · FY2011 · MH
Development Of New Approaches To Vaccines Against TBEV and West Nile Virus
$1,671,396Alexander Pletnev · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Adeno-associated Virus Biology And Utilization For Gene Transfer
$1,670,313John A Chiorini · National Institute Of Dental & Craniofacial Research · Z01 · FY2008 · DE
Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease
$1,669,694Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Disease mechanism and therapies for retinal degeneration
$1,668,911Tiansen Li · National Eye Institute · ZIA · FY2015 · EY
Neurophysiology Imaging Facility Core: Functional and Structural MRI
$1,668,120David A Leopold · National Institute Of Mental Health · ZIC · FY2014 · MH
Genometric analysis of quantitative traits
$1,668,057Alexander F Wilson · National Human Genome Research Institute · ZIA · FY2017 · HG
Studies of genetic and metabolic disorders, autism and premature aging
$1,667,480Owen Rennert · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD
Modeling bladder cancer pathogenesis and tumor evolution
$1,667,429Cory Abate-Shen · Columbia University Health Sciences · P01 · FY2019 · CA
Genomic profiling of influenza infections to identify biomarkers of disease severity
$1,666,018Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI